Biotech and Pharmaceutical
News & Jobs
Biotechnology and Pharmaceutical ChannelMedical Device and Diagnostics ChannelClinical Research Channel
Savient Pharmaceuticals, Inc. (NQ: SVNT)
Last Price  /  Updated: 4:00 PM EDT, Oct 16, 2013  /  Add to My Watchlist      
(SVNT) Community Analysis from
April 18, 2014
(Benzinga, 11/1/10)
Shares Savient Pharmaceuticals Inc (NASDAQ: SVNT) are spiking this morning on renewed takeover speculation. The stock opened up slightly trading fairly flat until volume came in around the 12.55 level pushing the stock up to 12.81 on...(read more)
(Benzinga, 10/25/10)
Savient Pharmaceuticals, Inc. (Nasdaq: SVNT) today announced that its previously announced process to identify, following the approval of KRYSTEXXA™ by the U.S. Food and Drug Administration, a strategic transaction for the sale of the...(read more)
(Hedge Accordingly, 9/14/10)
Strike this one up on the winners side of the FDA crap shoot board! Savient's gout drug,  Krystexxa; which was denied last year, has been approved by the FDA this evening. SVNT's shares are...(read more)
Savient Pharmaceuticals (SVNT) Company Overview

There is no analysis for SVNT yet. But you can go to Wikinvest to help create one!

Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here